NasdaqGS - Nasdaq Real Time Price • USD
Pacific Biosciences of California, Inc. (PACB)
As of 12:52 PM EDT. Market Open.
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 13 | 12 | 14 | 14 |
| Avg. Estimate | -0.27 | -0.25 | -1.02 | -0.82 |
| Low Estimate | -0.32 | -0.29 | -1.11 | -0.99 |
| High Estimate | -0.23 | -0.22 | -0.89 | -0.52 |
| Year Ago EPS | -0.36 | -0.28 | -1.21 | -1.02 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 11 | 10 | 14 | 14 |
| Avg. Estimate | 42.96M | 46.63M | 204.67M | 288.16M |
| Low Estimate | 38.75M | 41.24M | 171.8M | 224.97M |
| High Estimate | 51.4M | 58.2M | 240.4M | 386.5M |
| Year Ago Sales | 34.38M | -- | 200.52M | 204.67M |
| Sales Growth (year/est) | 25.00% | -- | 2.10% | 40.80% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -0.33 | -0.32 | -0.33 | -0.28 |
| EPS Actual | -0.36 | -0.28 | -0.26 | -0.31 |
| Difference | -0.03 | 0.04 | 0.07 | -0.03 |
| Surprise % | -9.10% | 12.50% | 21.20% | -10.70% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.27 | -0.25 | -1.02 | -0.82 |
| 7 Days Ago | -0.27 | -0.26 | -1.02 | -0.85 |
| 30 Days Ago | -0.27 | -0.26 | -1.03 | -0.85 |
| 60 Days Ago | -0.27 | -0.26 | -1.03 | -0.84 |
| 90 Days Ago | -0.27 | -0.25 | -1.01 | -0.76 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | 1 | 1 | 1 |
| Up Last 30 Days | 4 | 6 | 8 | 6 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | 1 | -- | 1 | 1 |
Growth Estimates
| CURRENCY IN USD | PACB | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 25.00% | -- | -- | 0.30% |
| Next Qtr. | 10.70% | -- | -- | 9.80% |
| Current Year | 15.70% | -- | -- | 4.50% |
| Next Year | 19.60% | -- | -- | 13.40% |
| Next 5 Years (per annum) | -1.00% | -- | -- | 11.06% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Downgrade | JP Morgan: Overweight to Neutral | 4/22/2024 |
| Maintains | Goldman Sachs: Neutral to Neutral | 4/19/2024 |
| Maintains | Bernstein: Outperform to Outperform | 4/18/2024 |
| Downgrade | Goldman Sachs: Buy to Neutral | 4/18/2024 |
| Maintains | Scotiabank: Sector Outperform to Sector Outperform | 4/18/2024 |
| Maintains | TD Cowen: Buy to Buy | 4/17/2024 |
Related Tickers
INVO INVO Bioscience, Inc.
1.1760
-9.54%
SINT Sintx Technologies, Inc.
0.0408
+13.89%
ABT Abbott Laboratories
106.52
-0.99%
NUWE Nuwellis, Inc.
0.2739
-7.59%
NNOX Nano-X Imaging Ltd.
9.11
-2.20%
INSP Inspire Medical Systems, Inc.
235.12
+0.51%
SENS Senseonics Holdings, Inc.
0.4430
+3.02%
TMDX TransMedics Group, Inc.
87.13
-3.83%
CUTR Cutera, Inc.
2.0493
-4.68%
INMD InMode Ltd.
17.17
-1.15%